| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |